EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Mitigating Effect and Mechanism of Polydeoxyribonucleotide Against Zoledronic Acid-Induced Growth Suppression of Human Gingival Fibroblasts

Shailashree Pachhapure, Young-Min Shin iD, Duk Gyu Kim, Dong-Rak Choi, Jong-Il Yun, Jae-Hong Kim, Byeong-Churl Jang

International Journal of Molecular Sciences · 24.11.2025 · 26 (23) · 11367

DOI: 10.3390/ijms262311367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.11.2025. Verfasst von Shailashree Pachhapure und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: Zoledronic Acid, Gingiva, Polydeoxyribonucleotides, Fibroblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by a grant (No. B20220018) from Zerone Cellvane Inc., Zerone Cellvane Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, is widely used to treat osteoporosis and bone metastases. However, its clinical application is limited by adverse effects, notably bisphosphonate-related osteonecrosis of the jaw (BRONJ), which is associated with cytotoxicity in oral mucosal cells. Polydeoxyribonucleotide (PDRN), a salmon sperm-derived DNA polymer with regenerative and anti-inflammatory properties, has shown therapeutic potential in tissue repair; however, its ability to mitigate ZA-induced cytotoxicity remains poorly understood. Here, we investigated the molecular mechanisms of ZA-induced toxicity in HGF-1 cells, a human gingival fibroblast line, and evaluated the protective effects of PDRN. ZA treatment (50 µM, 48 h) significantly inhibited HGF-1 cell growth, accompanied by reduced phosphorylation of protein kinase B (PKB) and signal transducer and activator of transcription 3 (STAT-3), along with increased phosphorylation of TANK-binding kinase 1 (TBK1). TBK1 silencing restored cell growth under ZA exposure, whereas silencing PKB or STAT-3 further suppressed cell growth even without ZA. Co-treatment with PDRN (100 µg/mL) effectively prevented and reversed ZA-induced HGF-1 cytotoxicity. Mechanistically, PDRN inhibited ZA-induced TBK1 phosphorylation and partially restored PKB phosphorylation, though it did not reverse the reduction in p-STAT-3. Additionally, ZA significantly elevated intracellular reactive oxygen species (ROS) levels at 8 h, which were attenuated by PDRN. The antioxidant N-acetylcysteine (NAC) similarly reduced ZA-induced ROS and p-TBK1 levels and improved cell growth, although it had limited effects on p-PKB at 8 h. Importantly, delayed PDRN treatment following ZA exposure reversed ZA-induced cell growth inhibition and TBK1 activation in a dose- and time-dependent manner. In summary, these findings demonstrate that ZA suppresses HGF-1 cell growth through ROS production, TBK1 activation, and inhibition of PKB and STAT-3, whereas PDRN counteracts these effects primarily by suppressing TBK1 activation and oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidGingivaPolydeoxyribonucleotidesFibroblastsHumansCell ProliferationSTAT3 Transcription FactorReactive Oxygen SpeciesCell LinePhosphorylationProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

HGF-1PDRNPKBTBK1zoledronic acid

Substanzen

Zoledronic AcidPolydeoxyribonucleotidesSTAT3 Transcription FactorReactive Oxygen SpeciesProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Molecular Medicine, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
  • Department of Dentistry, School of Medicine, Dongsan Hospital, Keimyung University, Daegu 42601, Republic of Korea.
  • Zerone Cellvane Inc., Cheonan 31035, Republic of Korea.
  • Yeon Dental Clinic, Seoul 04363, Republic of Korea.
  • Dental R&D Center, Zerone Cellvane Inc., Seoul 04363, Republic of Korea.
  • Seoul Top Dental Clinic, Namyangju-si 12232, Republic of Korea.

ORCID-Profile: Young-Min Shin

Förderung

  • This work was supported by a grant (No. B20220018) from Zerone Cellvane Inc.
  • Zerone Cellvane Inc.

Zitieren

APA

Pachhapure, S., Shin, Y. M., Kim, D. G., Choi, D. R., Yun, J. I., Kim, J. H., & Jang, B. C. (2025). The Mitigating Effect and Mechanism of Polydeoxyribonucleotide Against Zoledronic Acid-Induced Growth Suppression of Human Gingival Fibroblasts. International Journal of Molecular Sciences, 26(23), 11367. https://doi.org/10.3390/ijms262311367

Vancouver

Pachhapure S, Shin YM, Kim DG, Choi DR, Yun JI, Kim JH, et al. The Mitigating Effect and Mechanism of Polydeoxyribonucleotide Against Zoledronic Acid-Induced Growth Suppression of Human Gingival Fibroblasts. International Journal of Molecular Sciences. 2025;26(23):11367. doi:10.3390/ijms262311367

BibTeX
@article{Pachhapure2025,
  author = {Pachhapure, Shailashree and Shin, Young-Min and Kim, Duk Gyu and Choi, Dong-Rak and Yun, Jong-Il and Kim, Jae-Hong and Jang, Byeong-Churl},
  title = {The Mitigating Effect and Mechanism of Polydeoxyribonucleotide Against Zoledronic Acid-Induced Growth Suppression of Human Gingival Fibroblasts},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {23},
  pages = {11367},
  doi = {10.3390/ijms262311367}
}
Kostenlos starten →